Dr. Shi-Chi Cheng, MD

Dr. Cheng practices at Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL.

Dr. Cheng's NPI, 1164492427, was assigned on January 26, 2006. Dr. Cheng graduated from University of Chicago, Pritzker School of Medicine in 1992. Dr. Cheng holds Alabama license 21892.

Dr. Cheng's primary practice is Huntsville Hospital, at 101 Sivley Rd, Huntsville, AL 35801 in Madison County. The practice phone is (256) 265-1000.

Dr. Cheng's primary practice is Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL. Dr. Cheng is also affiliated with Marshall Medical Center South. The medical group on file is The Heart Center. Dmand AI also links Dr. Cheng to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cheng is licensed in Alabama.

CMS data shows 4,549 Medicare services from Dr. Cheng across 29 procedure codes in 2024, for 1,864 Medicare patients. Medicare paid $168,715 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,864 Medicare patients who saw Dr. Cheng in 2024. The largest group is 75 to 84, with 723 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 73, with 53% women.

In 2024, Dr. Cheng wrote 9,418 Medicare Part D claims for 933 patients. 80% of them were for generic drugs. CMS names the drug for 9,145 of them, across 69 drugs with 11 or more claims each, at $1,768,721 in total drug cost. In 2023, CMS named 7,741 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cheng for performance year 2024, reported through an alternative payment model (APM). Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 727 general payments to Dr. Cheng from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,225.

Dr. Cheng graduated from University of Chicago, Pritzker School of Medicine in 1992.